Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2015.664 | A Phase 3, Randomized, Double-Blind Study Comparing Upadacitinib (ABT-494) to Placebo in Subjects with Moderately to Severely Active Rheumatoid Arthritis Who Are on a Stable Dose of Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs) and Have an Inadequate Response to csDMARDs |
Prof. TAM Lai Shan 譚麗珊 |
| 2016.359 | A double-blind, randomised, placebo-controlled trial evaluating the effect of BI 655064 administered as sub-cutaneous injections, on renal response after one year of treatment, in patients with active lupus nephritis |
Prof. TAM Lai Shan 譚麗珊教授 |
| 2016.551 | A Randomized Open-label Study to Evaluate the Efficacy and Safety of Tacrolimus and Corticosteroids in Comparison with Mycophenolate Mofetil and Corticosteroids in Subjects with Class III/IV±V Lupus Nephritis |
Prof. TAM Lai Shan 譚麗珊 |
| 2016.037 | Identification and validation of microRNAs associated with inflammation detected by magnetic resonance imaging in patients with early rheumatoid arthritis. |
Prof. TAM Lai Shan 譚麗珊 |
| 2014.343 | Adaptation and validation of the Ankylosing Spondylitis Quality of Life (ASQOL) and Psoriatic Arthritis Quality of Life (PsAQOL) questionnaires in Hong Kong | Prof. TAM Lai Shan |
| 2013.300 | Immunopathological roles of the novel anti-inflammatory cytokine interleukin-35 in the patients with systemic lupus erythematous | Professor TAM Lai Shan |
| 2017.683 | Calprotectin in psoriatic arthritis |
Prof. TAM Lai Shan 譚麗珊 |
| 2013.469 | The Clinical Rheumatology Systematic Treat-to-target in Asia Leadership (CRYSTAL) Project | Prof. TAM Lai Shan |
| 2016.451 | Prevention of metacarpophalangeal joints structure damage in patients with psoriatic arthritis using secukinumab |
Prof. TAM Lai Shan 譚麗珊 |
| 2016.533 | A Randomized, Double-blind, Placebo- and Active-controlled, Multicenter, Phase 3 Study to Assess the Efficacy and Safety of Filgotinib Administered for 52 weeks in Combination with Methotrexate to Subjects with Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate |
Prof. TAM Lai Shan 譚麗珊 |
| 2014.387 | Coronary atherosclerosis in psoriatic arthritis | Prof. TAM Lai Shan |
| 2016.450 | Cost Effectiveness Analysis of Biologic Therapies for the Treatment of Rheumatoid Arthritis in Hong Kong |
Prof. TAM Lai Shan 譚麗珊教授 |
| 2013.451 | Immunopathological roles of the novel inflammatory cytokine interleukin-36 in the patients with systemic lupus erythematous | Professor TAM Lai Shan |
| 2017.295 | The long term renal outcome of biopsy proven paediatric lupus nephritis - a comparison of local and overseas cohort |
Prof. TAM Lai Shan 譚麗珊 |
| 2017.605 | Evaluation of molecular and cellular dysregulation in systemic lupus erythematosus | Prof. TAM Lai Shan |
| 2016.431 | Effect of RANKL inhibition on healing of bone erosion in rheumatoid arthritis using HR-pQCT |
Prof. TAM Lai Shan 譚麗珊 |
| 2017.446 | A Multicenter, Open-label, Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Subjects with Rheumatoid Arthritis |
Prof. TAM Lai Shan 譚麗珊 |
| 2016.390 | Assessment of structure changes after 4 years on the second and third metacarpophalangeal joint and distal radius in patients with psoriatic arthritis – a follow-up study using High-resolution peripheral quantitative CT (HR-pQCT) |
Prof. TAM Lai Shan 譚麗珊 |
| 2015.214 | Prevalence and risk factors for osteoporosis in patients with ankylosing spondylitis in Hong Kong: a cross-sectional cohort study |
Dr. TAM Lai Shan 譚麗珊 |
| 2017.239 | The Hong Kong Psoriatic Arthritis Screening program | Prof. TAM Lai Shan |
| 2017.389 | A Phase 3, Randomized, Double-Blind, Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Subjects with Active Psoriatic Arthritis Who Have a History of Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug (DMARD) – SELECT – PsA 1 | Prof. TAM Lai Shan |
| 2017.633 | An exploratory maintenance trial evaluating the effect of BI 655064 in Lupus Nephritis patients who have achieved a meaningful response either at the end of 1293.10 or after an induction treatment outside of 1293.10 |
Prof. TAM Lai Shan 譚麗珊教授 |
| 2016.366 | MicroRNAs as biomarkers for predicting the effect of anti-TNF and anti-IL6 in changes of bone erosions in rheumatoid arthritis using HR-pQCT |
Prof. TAM Lai Shan 譚麗珊 |
| 2017.261 | The impact of nurse-led programme with and without statin treatment base on traditional cardiovascular risk score or carotid ultrasound on addressing cardiovascular risk in patients with arthritis: a prospective, multicentre, randomised, controlled trial | Prof. TAM Lai Shan |
| 2017.700 | Circulating microRNA 99b as biomarker for predicting the early development, repair and progression of bone erosions in early rheumatoid arthritis using HR-pQCT |
Prof. TAM Lai Shan 譚麗珊 |
| 2024.185 | Outcomes of Transnasal Endoscopic Repair of Spontaneous Anterior Skull Base Cerebrospinal Fluid Leak - a Hong Kong Tertiary Center Review | Dr. TAM Ka Yue Aurora |
| 2024.363 | Nurse-led acceptance-based healthy lifestyles program for community-dwelling patients with pneumoconiosis: A waitlist pilot randomized controlled trial |
Dr. TAM Hon Lon 譚漢麟 |
| 2023.010 | A resource-oriented educational program on health behaviors among people at risk of metabolic syndrome | Dr. TAM Hon Lon |
| 2023.290 | Type 2 Diabetes Distress Assessment System and Acceptance and Action Diabetes Questionnaire: Validation of questionnaires in Chinese Population | Dr. TAM Hon Lon |
| 2023.498 | A mhealth social support program on health behaviors among people at risk of metabolic syndrome: a feasibility randomized controlled trial |
Dr. TAM Hon Lon 譚漢麟 |
| 2017.224 | Predicting excess hospital burden using temperature forecasts | Prof. TAM Greta Chun Huen |
| 2015.718 | Opt-out HIV testing in out-patient setting | Prof. TAM Greta Chun Huen |
| 2017.681 | Early growth genetics and cardiometabolic risk in Chinese adolescents |
Dr. TAM Claudia Ha Ting 譚夏亭 |
| 2023.560 | Clinical utility of lipoprotein(a) and its related polygenic risk score in risk stratification of cardiovascular complications among Chinese patients with type 2 diabetes |
Dr. TAM Claudia Ha Ting 譚夏亭 |
| 2009.632 | Walking balance of patients with ankle sprain after rehabilitations Vs normal people: A comparative study | Tam Choi Chi |
| 2022.123 | Case report of multisystemic smooth muscle dysfunction syndrome (MSMDS) in Hong Kong | Dr Tam Catherine Wing Yan |
| 2022.649 | Intracranial nasofrontal dermoid cyst and a hair in the nose tip without a sinus tract identified |
Dr. TAM Aurora Ka Yue 譚嘉裕 |
| 2021.170 | Randomised controlled trial of awake transnasal laser-assisted surgery (TNLS) and microlaryngeal surgery for benign laryngeal lesions | Dr. TAM Aurora Ka Yue |
| 2023.644 | Randomized controlled trial of awake transnasal laser-assisted surgery (TNLS) and microlaryngeal surgery for vocal cord cyst | Dr. TAM Aurora Ka Yue |
| 2009.357 | Non-Invasive Optical Biopsy in Cervical Specimens by Using Nonlinear Optical Microscopy: A Preliminary and Feasibility Study | Dr. Tak-Hong Cheung |
| 2020.213 | Exploring the relationship between oral health and quality of life among people with schizophrenia spectrum disorder in Tai Po district community | Ms. TAI Yik Shan |
| 2011.299 | The Capacity of Everyday Decision Making in Patients with Schizophrenia | Dr Tai Wing Ki |
| 2011.300 | Would Change in Subjective Perception of Illness Affect Duration of Acute Hospitalization in Chinese Patients with Schizophrenia? | Dr Tai Wing Ki |
| 2009.327 | Drug attitude of psychiatric patients and their relatives before and after a psychoeducation talk | Dr. Tai Wing Ki |
| 2016.448 | To understand the attitudes of the patients receiving palliative care, their relatives and health professionals towards using Traditional Chinese Medicine treatment in Hong Kong Palliative care. |
Miss TAI Pui Hei 戴沛希 |
| 2012.554 | A study to compare the “Ergomotor” Intervention Program to conventional physiotherapy treatment in managing work-related neck-shoulder disorders: A randomized controlled trial | Dr SZETO Pui Yuk Grace |
| 2009.057 | The Safety and Short-Term Efficacy of Aliskiren in the Treatment of Immunoglobulin A Nephropathy | Prof. Szeto Cheuk-Chun |
| 2008.057 | Reversal of Endotoxaemia and Vascular Dysfunction by Physiological Dialysis Solution in Diabetic Peritoneal Dialysis Patients | Dr. Szeto Cheuk-chun |
| 2009.009 | Urinary Micro-RNA Level ini Patients with Lupus Nephritis | Prof. Szeto Cheuk-Chun |
| 2009.007 | The Prevalence and Prognostic Implication of Malnutrition in Chinese Peritoneal Dialysis Patients | Prof. Szeto Cheuk-Chun |
Page 61 of 254.